Was Mankind Pharma's IPO a good idea?
Daybreak
00:00
The Rise of Mankind in the Consumer Health Business
Analysts are not happy with mankind because it has not provided the breakup of its consumer health business. It is spending less on research and development than what a company its size should be spending. If mankind really wants to maintain this growth, it will require more than just the reach and frequency of its field force which is already among the largest in the Indian farmer industry.
Play episode from 06:54
Transcript
